Australia markets closed

Kiromic BioPharma, Inc. (KRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7300-0.1100 (-3.87%)
At close: 04:00PM EST
2.7300 0.00 (0.00%)
Pre-market: 07:00AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
Operating expenses
Research development
7,296
5,053
1,202
1,425
Selling general and administrative
7,610
14,144
2,504
1,758
Total operating expenses
14,906
19,197
3,705
3,183
Operating income or loss
-14,906
-19,197
-3,705
-3,183
Interest expense
9.1
3.3
22.5
633.1
Income before tax
-14,809
-19,200
-3,728
-3,816
Income tax expense
-
-
0
0
Income from continuing operations
-14,809
-19,200
-3,728
-3,816
Net income
-14,809
-19,200
-3,728
-3,816
Net income available to common shareholders
-14,879
-19,913
-3,728
-3,816
Basic EPS
-
-4.42
-1.06
-1.08
Diluted EPS
-
-4.42
-1.06
-1.08
Basic average shares
-
4,506
3,533
3,533
Diluted average shares
-
4,506
3,533
3,533
EBITDA
-
-18,997
-3,618
-3,102